↓ Skip to main content

Mutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells

Overview of attention for article published in Breast Cancer Research, December 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#1 of 2,068)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

twitter
3924 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Mutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells
Published in
Breast Cancer Research, December 2020
DOI 10.1186/s13058-020-01370-y
Pubmed ID
Authors

Amr Ghaleb, Malik Padellan, Natalia Marchenko

X Demographics

X Demographics

The data shown below were collected from the profiles of 3,924 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 17%
Researcher 3 13%
Student > Ph. D. Student 3 13%
Other 2 8%
Student > Postgraduate 2 8%
Other 3 13%
Unknown 7 29%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 7 29%
Medicine and Dentistry 6 25%
Agricultural and Biological Sciences 1 4%
Nursing and Health Professions 1 4%
Immunology and Microbiology 1 4%
Other 1 4%
Unknown 7 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1020. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 June 2021.
All research outputs
#15,965
of 25,775,807 outputs
Outputs from Breast Cancer Research
#1
of 2,068 outputs
Outputs of similar age
#640
of 529,331 outputs
Outputs of similar age from Breast Cancer Research
#1
of 34 outputs
Altmetric has tracked 25,775,807 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,068 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.8. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 529,331 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.